Fidelity Investments
IDNA icon

Fidelity Investments’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Fidelity Investments’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Sell
94
-86
-48% -$2.58K ﹤0.01% 5096
2026
Q1 		$5.23K Buy
+180
New +$5.22K ﹤0.01% 4907
2025
Q1 		– Sell
-16
Closed -$362 – 5496
2024
Q4 		$362 Buy
16
+15
+1,500% +$360 ﹤0.01% 5016
2024
Q3 		$25 Sell
1
-22
-96% -$536 ﹤0.01% 5308
2024
Q2 		$532 Sell
23
-79
-77% -$1.85K ﹤0.01% 4859
2024
Q1 		$2.46K Buy
+102
New +$2.39K ﹤0.01% 4660
2023
Q4 		– Sell
-1
Closed -$20 – 5539
2023
Q3 		$20 Buy
+1
New +$22 ﹤0.01% 5089
2023
Q2 		– Sell
-69
Closed -$1.61K – 5489
2023
Q1 		$1.61K Buy
69
+68
+6,800% +$1.7K ﹤0.01% 4671
2022
Q4 		$25 Buy
+1
New +$27 ﹤0.01% 5070
2022
Q3 		– Sell
-8
Closed – – 5144
2022
Q2 		$0 Sell
8
-133
-94% -$3.97K ﹤0.01% 5201
2022
Q1 		$5K Sell
141
-688
-83% -$24.3K ﹤0.01% 4436
2021
Q4 		$36K Buy
829
+83
+11% +$3.93K ﹤0.01% 3309
2021
Q3 		$38K Buy
746
+89
+14% +$4.64K ﹤0.01% 3280
2021
Q2 		$34K Sell
657
-59
-8% -$2.77K ﹤0.01% 3248
2021
Q1 		$32K Buy
+716
New +$35K ﹤0.01% 3144

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments's IDNA Position: Q2 2026 in Review

Fidelity Investments reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 48% in Q2 2026, selling an estimated $2.58K and leaving 94 shares worth $3.16K. The position accounts for ﹤0.01% of the portfolio, ranked #5096.

Fidelity Investments first reported a position in IDNA in Q1 2021 and has held it in 15 quarters since. The position peaked at $38K in Q3 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Fidelity Investments held 94 shares of iShares Genomics Immunology and Healthcare ETF worth $3.16K as of Q2 2026.
  • Fidelity Investments sold 86 iShares Genomics Immunology and Healthcare ETF shares in Q2 2026, an estimated $2.58K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5096 holding.
  • Fidelity Investments first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2021 and has held it in 15 quarters since.
  • Fidelity Investments's iShares Genomics Immunology and Healthcare ETF position peaked at $38K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.